Basic Study
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. Sep 15, 2023; 15(9): 1531-1543
Published online Sep 15, 2023. doi: 10.4251/wjgo.v15.i9.1531
Table 1 Correlation between integrin binding sialoprotein expression and clinicopathologic characteristics in gastric cancer patients
Parameter
n
Low IBSP expression (n = 8)
High IBSP expression (n = 22)
P value
Age (yr)
≥ 6011470.361
< 6019415
Tumor diameter (cm)
≥ 310640.004a
< 320218
Gender
Male143110.544
Female16511
TNM stage
I + II7520.002a
III + IV23320
Distant metastasis
M0155100.409
M115312
Table 2 Cleavage and polyadenylation factor 6 regulates integrin binding sialoprotein to aggravate gastric cancer progression
No.
Findings in previous studies
Findings in this work
1IBSP has been discovered to exhibit higher expression and important regulatory function in colorectal cancer, breast cancer, and esophageal squamous cell carcinoma. However, the regulatory functions of IBSP in GC progression remain unclearIBSP exhibits higher expression in GC tissues and cell lines. IBSP facilitates GC cell proliferation, migration, and invasion but suppresses pyroptosis
2Previous studies have verified the oncological function of the RNA-binding protein CPSF6 in acute myeloid leukemia, breast cancer, and GC. However, no reports have focused on the regulatory effects of CPSF6 on metastasis and pyroptosisCPSF6 promotes cell proliferation, migration, and invasion but boosts pyroptosis
3The RNA-binding protein CPSF6 binds to the 3’-UTR of genes to participate in the progression of hepatocellular carcinoma, lung adenocarcinoma, and GC. But, the relationship between IBSP and CPSF6 has not been studied in GC progressionCPSF6 binds to the 3’-UTR of IBSP and positively regulates IBSP expression
4The regulatory mechanism (RNA binding protein-mRNA 3’-UTR) exists in GC progression. However, the regulatory effects of CPSF6/IBSP remain unclearThe retarded GC progression mediated by CPSF6 knockdown is reversed by IBSP overexpression